Hrt Financial LP Codexis, Inc. Transaction History

Hrt Financial LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$3.81 - $6.76 $767,231 - $1.36 Million	201,373 Added 355.96%	257,945 $1.07 Million
Q4 2022 Feb 10, 2023	BUY	$4.26 - $6.84 $184,896 - $296,876	43,403 Added 329.58%	56,572 $263,000
Q3 2022 Nov 14, 2022	BUY	$6.06 - $12.86 $79,804 - $169,353	13,169 New	13,169 $79,000
Q3 2021 Nov 15, 2021	SELL	$19.65 - $27.99 $2.17 Million - $3.08 Million	-110,203 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$17.48 - $25.46 $1.58 Million - $2.31 Million	90,552 Added 460.8%	110,203 $2.5 Million
Q1 2021 May 17, 2021	SELL	$18.08 - $28.8 $227,627 - $362,592	-12,590 Reduced 39.05%	19,651 $449,000
Q4 2020 Feb 16, 2021	BUY	$11.7 - $23.41 $377,219 - $754,761	32,241 New	32,241 $703,000

125

59.9M

25.9K

20.1K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $335M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.